Structure Therapeutics Inc. — Director's Dealing 2023

Aug 4, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Structure Therapeutics Inc. (GPCR)
CIK: 0001888886
Period of Report: 2023-08-03

Reporting Person: WELCH DANIEL G (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-03	Stock option (right to buy)	$2.60	J	411000	Disposed	2032-01-19	Ordinary Shares (411000)	Direct
2023-08-03	Stock option (right to buy)	$2.60	J	205500	Acquired	2032-01-19	Ordinary Shares (205500)	Indirect
2023-08-03	Stock option (right to buy)	$2.60	J	205500	Acquired	2032-01-19	Ordinary Shares (205500)	Indirect

Footnotes

F1: The reported transactions involve the Reporting Person's transfer of the vested portion of his option to trusts established for the benefit of his
children. The transfer was a substitution for minority interests in a family limited partnership of equivalent value previously gifted to the trusts. The price per share is 1/3 of the closing price of the Issuer's American Depositary Shares ("ADS") on the date of transfer less the exercise price per share of the option. Each ADS consist of three of the Issuer's ordinary shares.

F2: 1/3rd of the shares vested one year after January 5, 2022 (the "Vesting Commencement Date"); the balance of the shares vest in a series of 24 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.

F3: The option is held by the Andrew J. Welch 2020 Irrevocable GST Trust, dated July 1, 2020. The Reporting Person is trustee of such trust and his son is the sole beneficiary of such trust.

F4: The option is held by the Michael D. Welch 2020 Irrevocable GST Trust, dated July 1, 2020. The Reporting Person is trustee of such trust and his son and such son's descendants are the sole beneficiaries of such trust.